Effects of inflammation on irinotecan pharmacokinetics and development of a best-fit PK modelPavan Kumar Chityala, Romi Ghose, Lei Wu et al.|Chemico-Biological Interactions|2019Cited by 10
Development of a physiologically based pharmacokinetic model to predict irinotecan disposition during inflammationGabriel Tao, Romi Ghose, Li Li et al.|Chemico-Biological Interactions|2022Cited by 4
Differential Regulation of Hepatic UDP‐glucuronosyltransferase (UGT) 1A1 by Toll‐like Receptors during Irinotecan‐induced SteatosisGabriel Tao, Romi Ghose, Pavan Kumar Chityala|The FASEB Journal|2020Cited by 3
A Pharmacokinetic Study of Irinotecan (CPT‐11) During Inflammation in MicePavan Kumar Chityala, Romi Ghose, Guncha Taneja et al.|The FASEB Journal|2018Cited by 1
Altered Irinotecan Pharmacokinetics During Inflammation in MicePavan Kumar Chityala, Romi Ghose, Song Gao et al.|The FASEB Journal|2017Cited by 1